Considering the higher median PSA level in newly diagnosed PCa patients in China than in Western countries [13], some scholars also suggest that the “diagnostic gray zone” of PCa be broadened to 4–20.0 ng/mL in order to reduce unnecessary biopsy [14]. The gene discussed is KLK3; the disease is posterior cortical atrophy.